| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 74,366 | 69,120 | 100,840 | 170,695 | | Cost of Revenue | 51,953 | 43,343 | 62,844 | 97,957 | | | Gross Profit | 22,413 | 25,777 | 37,996 | 72,738 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,892 | 8,951 | 10,027 | 12,122 | | Non Recurring | (1,713) |
-
|
-
| 171,493 | | Others | 27,256 | 26,099 | 25,112 | 26,860 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (12,022) | (9,273) | 2,857 | (137,737) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 265 | 1,195 | (431) | 732 | | Earnings Before Interest And Taxes | (11,757) | (8,078) | 2,426 | (137,005) | | Interest Expense | 1,839 | 1,728 | 1,988 | 3,460 | | Income Before Tax | (13,596) | (9,806) | 438 | (140,465) | | Income Tax Expense | (4,406) | (3,547) | (180) | (22,562) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,190) | (6,259) | 618 | (117,903) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,190) | (6,259) | 618 | (117,903) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,190) | ($6,259) | $618 | ($117,903) |
|
0.31% Nasdaq 
0.05%
Income Statement
